Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
T(H)17 lymphocytes appear to be essential in the pathogenesis of numerous inflammatory diseases. We demonstrate here the expression of IL-17 and IL-22 receptors on blood-brain barrier endothelial cells (BBB-ECs) in multiple sclerosis lesions, and show that IL-17 and IL-22 disrupt BBB tight junctions in vitro and in vivo. Furthermore, T(H)17 lymphocytes transmigrate efficiently across BBB-ECs, highly express granzyme B, kill human neurons and promote central nervous system inflammation through CD4+ lymphocyte recruitment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In turn, IL-17 further impairs BBB integrity, thus allowing more immune cells and cytokines to gain easy access to the CNS [65, 66].”
From Chronic stress-induced depression requires the recruitment of peripheral Th17 cells into the brain (2022) · cites this paper as [66]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“IL-17 impairs blood–brain barrier integrity, allowing for more immune cells to cross into the CNS [127,128].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [128]
The cited source says what the claim attributes to it.
In the citing paper
“a subset of CD4+ T cells that is a major contributor to the pathogenicity of several inflammatory and autoimmune conditions (9–11)”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“inflammatory subtypes of T cells, particularly Th17 cells, are clearly deleterious in diseases such as multiple sclerosis (9–11, 24)”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“Th17 cells are deleterious to the CNS”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., & Iwakura, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.566 · Cited by 1,536
Steinman, L. (2007) · Nature Medicine · doi:10.1038/nm1551 · Cited by 1,376
Loss of T-bet, But Not STAT1, Prevents the Development of Experimental Autoimmune Encephalomyelitis
Bettelli, E., Sullivan, B., Szabo, S. J., Sobel, R. A., Glimcher, L. H., & Kuchroo, V. K. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031819 · Cited by 488
Wosik, K., Cayrol, R., Dodelet-Devillers, A., Berthelet, F., Bernard, M., Moumdjian, R., Bouthillier, A., Reudelhuber, T. L., & Prat, A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2088-07.2007 · Cited by 259
Self-citationExpression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes
Chung, Y., Yang, X., Chang, S. H., Ma, L., Tian, Q., & Dong, C. (2006) · Cell Research · doi:10.1038/sj.cr.7310106 · Cited by 231
Cited by
Items 101–200 of 1,003
Barrier function in the peripheral and central nervous system—a review
Reinhold, A., & Rittner, H. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-016-1920-8 · Cited by 275
Th17 Cells in Immunity and Autoimmunity
Bedoya, S. K., Lam, B., Lau, K., & Larkin, J. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/986789 · Cited by 282
“[153] H.”
InfluentialCrome, S. Q., Wang, A. Y., & Levings, M. K. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.04037.x · Cited by 275
Inflammatory mediators in human epilepsy: A systematic review and meta-analysis
de Vries, E. E., van den Munckhof, B., Braun, K. P. J., van Royen-Kerkhof, A., de Jager, W., & Jansen, F. E. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.02.007 · Cited by 269
Smolders, J., Thewissen, M., Peelen, E., Menheere, P., Cohen Tervaert, J. W., Damoiseaux, J., & Hupperts, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006635 · Cited by 270
“More recently interleukin-17 (IL-17) producing Th17 cells have been argued to be important pathogenic T cells in MS [3,4].”
BackgroundNKT Cell-Dependent Amelioration of a Mouse Model of Multiple Sclerosis by Altering Gut Flora
Yokote, H., Miyake, S., Croxford, J. L., Oki, S., Mizusawa, H., & Yamamura, T. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080622 · Cited by 264
Sodium intake is associated with increased disease activity in multiple sclerosis
Farez, M. F., Fiol, M. P., Gaitán, M. I., Quintana, F. J., & Correale, J. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-307928 · Cited by 267
Cellular and Molecular Mediators of Neuroinflammation in the Pathogenesis of Parkinson’s Disease
More, S. V., Kumar, H., Kim, I. S., Song, S.-Y., & Choi, D.-K. (2013) · Mediators of Inflammation · doi:10.1155/2013/952375 · Cited by 258
Appel, S. H., Beers, D. R., & Henkel, J. S. (2010) · Trends in Immunology · doi:10.1016/j.it.2009.09.003 · Cited by 256
“Th17 cells may also contribute to neurotoxicity possibly through the secretion of IL-17 or the release of granzyme B, a cytolytic enzyme (see Figure 1) [37].”
BackgroundInflammatory T helper 17 cells promote depression-like behavior in mice
Beurel, E., Harrington, L. E., & Jope, R. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.021 · Cited by 254
Interleukin-17 in chronic inflammatory neurological diseases
Milovanovic, J., Arsenijevic, A., Stojanovic, B., Kanjevac, T., Arsenijevic, D., Radosavljevic, G., Milovanovic, M., & Arsenijevic, N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00947 · Cited by 250
“Although ischemia-reperfusion induces necrosis of blood–brain barrier, IL-17 could enhance BBB damage by the disruption of tight junctions (120) and by the promotion of monocyte migration across the BBB through an intracellular adhesion molecule (ICAM) 1-dependent mechanism (159).”
BackgroundInfluentialThe role of T cells in age-related diseases
Carrasco, E., Gómez de las Heras, M. M., Gabandé-Rodríguez, E., Desdín-Micó, G., Aranda, J. F., & Mittelbrunn, M. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00557-4 · Cited by 239
Relationship between intracortical electrode design and chronic recording function
Karumbaiah, L., Saxena, T., Carlson, D., Patil, K., Patkar, R., Gaupp, E. A., Betancur, M., Stanley, G. B., Carin, L., & Bellamkonda, R. V. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.016 · Cited by 241
“TH-17 cells are key effectors of neuroinflammatory disorders such as MS and experimental autoimmune encephalomyelitis, which results from the disruption of BBB tight junctions via a mechanism involving IL17 secretion and binding to endothelial cell IL17 receptors, followed by granzyme B induced neurotoxicity and infla…”
BackgroundTh17 cells: from precursors to players in inflammation and infection
Awasthi, A., & Kuchroo, V. K. (2009) · International Immunology · doi:10.1093/intimm/dxp021 · Cited by 241
The Role of IL-17 and Th17 Lymphocytes in Autoimmune Diseases
Tabarkiewicz, J., Pogoda, K., Karczmarczyk, A., Pozarowski, P., & Giannopoulos, K. (2015) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-015-0344-z · Cited by 238
“Autoreactive Th17 cells can disrupt tight junction proteins in the central nervous system endothelial cells and migrate through the BBB and this effect is mediated via IL-17 and IL-22 (Kebir et al. 2007).”
BackgroundIL-17 and Th17 cells in human inflammatory diseases
Miossec, P. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.04.003 · Cited by 236
Sanchez-Guajardo, V., Barnum, C. J., Tansey, M. G., & Romero-Ramos, M. (2013) · ASN Neuro · doi:10.1042/an20120066 · Cited by 236
“Do they change the cytokine microenvironment to polarize glia or signal to neurons (Kebir et al., 2007; Mount et al., 2007)?”
BackgroundZhang, J., Ke, K.-F., Liu, Z., Qiu, Y.-H., & Peng, Y.-P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075786 · Cited by 233
The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis
Schön, M. P., & Erpenbeck, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01323 · Cited by 233
“Th17 cells are prominently involved in the pathogenesis of psoriasis (43–45), palmoplantar pustulosis (46), as well as other chronic inflammatory diseases (47, 48).”
BackgroundWitte, E., Witte, K., Warszawska, K., Sabat, R., & Wolk, K. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.08.002 · Cited by 233
“infiltratedmultiple sclerosis lesions, to promote the diffusion of BSA through monolayers of blood brain barrier endothelial cells, and to increase CCL2 production by these cells [87].”
BackgroundT Helper Cells: The Modulators of Inflammation in Multiple Sclerosis
Kunkl, M., Frascolla, S., Amormino, C., Volpe, E., & Tuosto, L. (2020) · Cells · doi:10.3390/cells9020482 · Cited by 232
“IL-17A in combination with IL-6 has been also described to promote the breakdown of BBB in RRMS patients [71] by altering the expression of adhesion molecules on endothelial cells [72,73] and favoring the depolymerization of the actin cytoskeleton near the tight junctions [74].”
BackgroundCruz-Orengo, L., Holman, D. W., Dorsey, D., Zhou, L., Zhang, P., Wright, M., McCandless, E. E., Patel, J. R., Luker, G. D., Littman, D. R., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20102010 · Cited by 231
Signaling of interleukin-17 family cytokines in immunity and inflammation
Chang, S. H., & Dong, C. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2010.11.022 · Cited by 229
Gong, W., Guo, P., Li, Y., Liu, L., Yan, R., Liu, S., Wang, S., Xue, F., Zhou, X., & Yuan, Z. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.4974 · Cited by 225
IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease
Zepp, J., Wu, L., & Li, X. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.02.007 · Cited by 224
van Langelaar, J., van der Vuurst de Vries, R. M., Janssen, M., Wierenga-Wolf, A. F., Spilt, I. M., Siepman, T. A., Dankers, W., Verjans, G. M. G. M., de Vries, H. E., Lubberts, E., et al. (2018) · Brain · doi:10.1093/brain/awy069 · Cited by 222
“Interleukin-17 (IL-17) and C-C chemokine receptor 6 (CCR6) are key determinants for Th17 transmigration across the blood–brain barrier (Kebir et al., 2007; Reboldi et al., 2009).”
BackgroundDeciphering the role of Th17 cells in human disease
Wilke, C. M., Bishop, K., Fox, D., & Zou, W. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.08.003 · Cited by 224
“Furthermore, treatment of BBB-EC with IL-17 or IL-22 made it easier for human PBMC CD4+ T cells to travel through the monolayer[59].”
MethodAstrocytic tight junctions control inflammatory CNS lesion pathogenesis
Horng, S., Therattil, A., Moyon, S., Gordon, A., Kim, K., Argaw, A. T., Hara, Y., Mariani, J. N., Sawai, S., Flodby, P., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91301 · Cited by 221
Post-Ischemic Inflammation in the Brain
Shichita, T., Sakaguchi, R., Suzuki, M., & Yoshimura, A. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00132 · Cited by 218
Lee, S. K., Kim, J. Y., Hur, S. E., Kim, C. J., Na, B. J., Lee, M., Gilman-Sachs, A., & Kwak-Kim, J. (2011) · Human Reproduction · doi:10.1093/humrep/der301 · Cited by 217
“nervous system inflammation (Kebir et al., 2007).”
From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited
Boniface, K., Blom, B., Liu, Y., & De Waal Malefyt, R. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00714.x · Cited by 218
“Prat and colleagues (44) directly investigated the involvement of human Th17 cells in central nervous inflammation.”
BackgroundTh17 Cells and Autoimmune Encephalomyelitis (EAE/MS)
Aranami, T., & Yamamura, T. (2008) · Allergology International · doi:10.2332/allergolint.r-07-159 · Cited by 218
Zhang, L., Li, Y.-G., Li, Y.-H., Qi, L., Liu, X.-G., Yuan, C.-Z., Hu, N.-W., Ma, D.-X., Li, Z.-F., Yang, Q., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031000 · Cited by 216
“Besides, Th17 cells are considered to be involved in many human inflammatory diseases, including multiple sclerosis, psoriasis and inflammatory arthritis [11–15].”
BackgroundArif, S., Moore, F., Marks, K., Bouckenooghe, T., Dayan, C. M., Planas, R., Vives-Pi, M., Powrie, J., Tree, T., Marchetti, P., et al. (2011) · Diabetes · doi:10.2337/db10-1643 · Cited by 213
“It is noteworthy that a clear link to immunopathogenesis has been made through the demonstration that TH17 cells disrupt blood-brain barrier tight junctions, enabling transmigration of immune-competent cells into the brain parenchyma and the establishment of local inflammation (6).”
BackgroundMelatonin signaling in T cells: Functions and applications
Ren, W., Liu, G., Chen, S., Yin, J., Wang, J., Tan, B., Wu, G., Bazer, F. W., Peng, Y., Li, T., et al. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12394 · Cited by 209
IL-17–producing T cells in lung immunity and inflammation
Nembrini, C., Marsland, B. J., & Kopf, M. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.03.033 · Cited by 210
Chen, Y., Jiang, T., Chen, P., Ouyang, J., Xu, G., Zeng, Z., & Sun, Y. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2010.10.029 · Cited by 209
Behçet’s disease physiopathology: a contemporary review
Zeidan, M. J., Saadoun, D., Garrido, M., Klatzmann, D., Six, A., & Cacoub, P. (2016) · Autoimmunity Highlights · doi:10.1007/s13317-016-0074-1 · Cited by 202
“In this context, IL-21 blocking agents (neutralizing antibodies or receptors) have been suggested for patients with severe or refractory BD, given that IL-21 blockade restored the altered balance between Th17 cells and Tregs [35, 67, 70, 89].”
BackgroundInfluentialCD4 + T cells contribute to neurodegeneration in Lewy body dementia
Gate, D., Tapp, E., Leventhal, O., Shahid, M., Nonninger, T. J., Yang, A. C., Strempfl, K., Unger, M. S., Fehlmann, T., Oh, H., et al. (2021) · Science · doi:10.1126/science.abf7266 · Cited by 214
“Moreover, human Th17 cells have been shown to promote blood-brain barrier disruption and central nervous system inflammation via IL-17A (33).”
BackgroundInfluentialThe Interleukin-10 Family of Cytokines and Their Role in the CNS
Burmeister, A. R., & Marriott, I. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00458 · Cited by 207
Liu, Z., Qiu, A.-W., Huang, Y., Yang, Y., Chen, J.-N., Gu, T.-T., Cao, B.-B., Qiu, Y.-H., & Peng, Y.-P. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.07.026 · Cited by 207
Nouri, M., Bredberg, A., Weström, B., & Lavasani, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106335 · Cited by 206
“Th1 cells enter the CNS during EAE development and then promote the subsequent infiltration and activation of Th17 cells [28].”
BackgroundInfluentialMicro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity
Guerau-de-Arellano, M., Smith, K. M., Godlewski, J., Liu, Y., Winger, R., Lawler, S. E., Whitacre, C. C., Racke, M. K., & Lovett-Racke, A. E. (2011) · Brain · doi:10.1093/brain/awr262 · Cited by 188
Regulation and Function of Proinflammatory TH17 Cells
Martinez, G. J., Nurieva, R. I., Yang, X. O., & Dong, C. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1443.021 · Cited by 203
Adverse functions of IL‐17A in experimental sepsis
Flierl, M. A., Rittirsch, D., Gao, H., Hoesel, L. M., Nadeau, B. A., Day, D. E., Zetoune, F. S., Sarma, J. V., Huber-Lang, M. S., Ferrara, J. L. M., et al. (2008) · The FASEB Journal · doi:10.1096/fj.07-105221 · Cited by 203
Ifergan, I., Kebir, H., Bernard, M., Wosik, K., Dodelet-Devillers, A., Cayrol, R., Arbour, N., & Prat, A. (2008) · Brain · doi:10.1093/brain/awm295 · Cited by 196
Self-citationEtiology and Pathogenesis of Psoriasis
Boehncke, W.-H. (2015) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.07.013 · Cited by 197
Adaptive and Innate Immunity in Psoriasis and Other Inflammatory Disorders
Schön, M. P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01764 · Cited by 193
“In psoriasis (31, 101, 102), palmoplantar pustulosis (103) and other inflammatory disorders (104, 105), Th17 lymphocytes are vastly expanded and are thought to contribute decisively to the pathogenesis of these conditions (Figure 3).”
BackgroundMultiple Sclerosis and T Lymphocytes: An Entangled Story
Legroux, L., & Arbour, N. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9614-0 · Cited by 196
“Human MAITs express high levels of CD161, CCR6 and cytokine receptors (IL-12, IL-18 and IL-23) and can produce inflammatory cytokines including IFN-γ and IL-17 (Gapin 2014).”
BackgroundInfluentialSelf-citationVasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions
Delgado, M., & Ganea, D. (2013) · Amino Acids · doi:10.1007/s00726-011-1184-8 · Cited by 192
IL‐23: One cytokine in control of autoimmunity
Croxford, A. L., Mair, F., & Becher, B. (2012) · European Journal of Immunology · doi:10.1002/eji.201242598 · Cited by 193
Self-citationAbrahamsson, S. V., Angelini, D. F., Dubinsky, A. N., Morel, E., Oh, U., Jones, J. L., Carassiti, D., Reynolds, R., Salvetti, M., Calabresi, P. A., et al. (2013) · Brain · doi:10.1093/brain/awt182 · Cited by 194
“MAITs produce high levels of inflammatory cytokines IFN- and TNF- , and are the highest CD8 + producers of IL-17; IL-17R is expressed on blood– brain barrier epithelial cells in multiple sclerosis lesions and IL-17 increases the permeability of the barrier (Kebir et al., 2007).”
BackgroundCNS Infiltration of Peripheral Immune Cells: D-Day for Neurodegenerative Disease?
Rezai-Zadeh, K., Gate, D., & Town, T. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9166-2 · Cited by 197
Chen, S., Li, L., Peng, C., Bian, C., Ocak, P. E., Zhang, J. H., Yang, Y., Zhou, D., Chen, G., & Luo, Y. (2022) · Antioxidants & Redox Signaling · doi:10.1089/ars.2021.0072 · Cited by 186
Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis
Mehling, M., Lindberg, R., Raulf, F., Kuhle, J., Hess, C., Kappos, L., & Brinkmann, V. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ebdd64 · Cited by 195
Defining the human T helper 17 cell phenotype
Annunziato, F., Cosmi, L., Liotta, F., Maggi, E., & Romagnani, S. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.05.004 · Cited by 191
Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology
Peery, H. E., Day, G. S., Dunn, S., Fritzler, M. J., Prüss, H., De Souza, C., Doja, A., Mossman, K., Resch, L., Xia, C., et al. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.03.001 · Cited by 192
“Innate cytokines or TLR ligands can activate transport systems within the BBB endothelium [88], while IL-17 produced by autoreactive Th17 cells can also induce disruption of tight junctions between endothelial cells making the BBB more permeable [89,91], and allowing autoreactive memory B cells and plasma cells to ent…”
BackgroundAl-Obaidi, M. M. J., & Desa, M. N. M. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0609-2 · Cited by 188
Rahman, M. T., Ghosh, C., Hossain, M., Linfield, D., Rezaee, F., Janigro, D., Marchi, N., & van Boxel-Dezaire, A. H. H. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.11.021 · Cited by 189
Boniface, K., Blumenschein, W. M., Brovont-Porth, K., McGeachy, M. J., Basham, B., Desai, B., Pierce, R., McClanahan, T. K., Sadekova, S., & de Waal Malefyt, R. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000366 · Cited by 187
Schmechel, S., Konrad, A., Diegelmann, J., Glas, J., Wetzke, M., Paschos, E., Lohse, P., Göke, B., & Brand, S. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20315 · Cited by 189
Tight Junctions in Brain Barriers During Central Nervous System Inflammation
Coisne, C., & Engelhardt, B. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3929 · Cited by 186
“TH17 cells were reported to impair BBB integrity through the combined production of interleukin (IL)- 17A and IL-22 that downregulated occludin and to a lesser extend ZO-1 (65).”
Shan, M., Yuan, X., Song, L.-Z., Roberts, L., Zarinkamar, N., Seryshev, A., Zhang, Y., Hilsenbeck, S., Chang, S.-H., Dong, C., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003041 · Cited by 187
Netrin 1 regulates blood–brain barrier function and neuroinflammation
Podjaski, C., Alvarez, J. I., Bourbonniere, L., Larouche, S., Terouz, S., Bin, J. M., Lécuyer, M.-A., Saint-Laurent, O., Larochelle, C., Darlington, P. J., et al. (2015) · Brain · doi:10.1093/brain/awv092 · Cited by 185
“In several inflammatory brain pathologies, including multiple sclerosis, trauma and stroke, pro-inflammatory mediators contribute to junctional complex breakdown, causing blood–brain barrier dysfunction (Unterberg et al., 2004; Kebir et al., 2007; Cayrol et al., 2008; Altman and Rutledge, 2010).”
BackgroundSelf-citationde Boer, O. J., van der Meer, J. J., Teeling, P., van der Loos, C. M., Idu, M. M., van Maldegem, F., Aten, J., & van der Wal, A. C. (2010) · The Journal of Pathology · doi:10.1002/path.2667 · Cited by 183
“Recent studies have shown that TH17 cells are crucial effector cells in several chronic inflammatory diseases that were considered to be TH1-mediated, eg multiple sclerosis [7], rheumatoid arthritis [8], inflammatory bowel disease [9] and systemic lupus erythematosus (SLE) [10].”
BackgroundInvolvement of the Warburg effect in non‐tumor diseases processes
Chen, Z., Liu, M., Li, L., & Chen, L. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25998 · Cited by 185
“CD4+ T Cell dysfunctions play a pivotal role in MS pathogenesis, which can induce axonal damage and neuronal death (Goverman, 2009; Kebir et al., 2007).”
BackgroundThe anti-CD20 antibody rituximab reduces the Th17 cell response
van de Veerdonk, F. L., Lauwerys, B., Marijnissen, R. J., Timmermans, K., Di Padova, F., Koenders, M. I., Gutierrez-Roelens, I., Durez, P., Netea, M. G., van der Meer, J. W. M., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30314 · Cited by 180
Havrdova, E., Horakova, D., & Kovarova, I. (2015) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285614563522 · Cited by 176
Intracellular MLCK1 diversion reverses barrier loss to restore mucosal homeostasis
Graham, W. V., He, W., Marchiando, A. M., Zha, J., Singh, G., Li, H.-S., Biswas, A., Ong, M. L. D. M., Jiang, Z.-H., Choi, W., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0393-7 · Cited by 176
Mechanisms regulating regional localization of inflammation during CNS autoimmunity
Pierson, E., Simmons, S. B., Castelli, L., & Goverman, J. M. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01126.x · Cited by 175
“Human endothelial cells express IL-17 receptor, and IL-17 disrupts tight junctions in the blood–brain barrier to facilitate the migration of CD4 T cells across the blood– brain barrier in humans and mice (42, 79).”
BackgroundThe Immunopathophysiology of Multiple Sclerosis
Wu, G. F., & Alvarez, E. (2011) · Neurologic Clinics · doi:10.1016/j.ncl.2010.12.009 · Cited by 172
Modeling the heterogeneity of multiple sclerosis in animals
Simmons, S. B., Pierson, E. R., Lee, S. Y., & Goverman, J. M. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.04.006 · Cited by 174
IL-6, IL-17 and STAT3: a holy trinity in auto-immunity?
Camporeale, A. (2012) · Frontiers in Bioscience · doi:10.2741/4054 · Cited by 176
“These in turn favour disruption of the tight-junctions and increased vessels permeabilization, thus promoting transmigration of CD4 T lymphocytes (126).”
BackgroundVillegas-Mendez, A., Greig, R., Shaw, T. N., de Souza, J. B., Gwyer Findlay, E., Stumhofer, J. S., Hafalla, J. C. R., Blount, D. G., Hunter, C. A., Riley, E. M., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200688 · Cited by 177
“to neuropathology during malaria infection, including direct neuronal damage (26), disruption of the blood–brain barrier (27), and activation of astrocytes (28, 29).”
BackgroundInflammation in Neurological Disorders: A Help or a Hindrance?
Wee Yong, V. (2010) · The Neuroscientist · doi:10.1177/1073858410371379 · Cited by 174
NETosis in Alzheimer’s Disease
Pietronigro, E. C., Della Bianca, V., Zenaro, E., & Constantin, G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00211 · Cited by 175
“IL-17 is a cytotoxic cytokine for neurons and may contribute to the loss of BBB integrity and the recruitment of neutrophils in other inflammatory CNS diseases (117, 118).”
BackgroundSarma, J. D., Ciric, B., Marek, R., Sadhukhan, S., Caruso, M. L., Shafagh, J., Fitzgerald, D. C., Shindler, K. S., & Rostami, A. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-14 · Cited by 174
“Expression of IL-17RA in the CNS of healthy human subjects is undetectable by immunofluorescence but the receptor was expressed in CNS endothelial cells within heavily infiltrated MS lesions [27].”
InfluentialRepositioning TH cell polarization from single cytokines to complex help
Tuzlak, S., Dejean, A. S., Iannacone, M., Quintana, F. J., Waisman, A., Ginhoux, F., Korn, T., & Becher, B. (2021) · Nature Immunology · doi:10.1038/s41590-021-01009-w · Cited by 171
Self-citationRossi, B., Angiari, S., Zenaro, E., Budui, S. L., & Constantin, G. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0710432 · Cited by 172
Multiple sclerosis immunology: The healthy immune system vs the MS immune system
Kasper, L. H., & Shoemaker, J. (2010) · Neurology · doi:10.1212/wnl.0b013e3181c97c8f · Cited by 166
Role of ninjurin‐1 in the migration of myeloid cells to central nervous system inflammatory lesions
Ifergan, I., Kebir, H., Terouz, S., Alvarez, J. I., Lécuyer, M., Gendron, S., Bourbonnière, L., Dunay, I. R., Bouthillier, A., Moumdjian, R., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22519 · Cited by 166
“Canada) and Jackson Laboratory (Bar Harbor, ME), as previously published.(29,30) Starting on day 3 post-immunization,”
BackgroundSelf-citationCao, W., Yang, Y., Wang, Z., Liu, A., Fang, L., Wu, F., Hong, J., Shi, Y., Leung, S., Dong, C., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.06.011 · Cited by 167
“Th17 cells have been found in the brain lesions of patients with MS, and elevated amounts of IL-17 have been reported in their serum and cerebrospinal fluid (Kebir et al., 2007; Tzartos et al., 2008).”
BackgroundInnate and Adaptive Autoimmunity Directed to the Central Nervous System
Bhat, R., & Steinman, L. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.015 · Cited by 167
Chang, J.-H., Cha, H.-R., Lee, D.-S., Seo, K. Y., & Kweon, M.-N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012925 · Cited by 165
“Rather IL-17 and IL-22 receptors on blood-brain barrier endothelial cells play a crucial role on ICAM-1-mediated migration of TH17 in MS [8,11].”
BackgroundPericytes regulate vascular immune homeostasis in the CNS
Török, O., Schreiner, B., Schaffenrath, J., Tsai, H.-C., Maheshwari, U., Stifter, S. A., Welsh, C., Amorim, A., Sridhar, S., Utz, S. G., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016587118 · Cited by 166
Self-citationHu, B., & Arya, A. (2018) · Brain Circulation · doi:10.4103/bc.bc_32_18 · Cited by 166
Sphingosine‐1‐phosphate receptor 1 signalling in T cells: trafficking and beyond
Garris, C. S., Blaho, V. A., Hla, T., & Han, M. H. (2014) · Immunology · doi:10.1111/imm.12272 · Cited by 162
IL-23 and TH17-mediated inflammation in human allergic contact dermatitis
Larsen, J. M., Bonefeld, C. M., Poulsen, S. S., Geisler, C., & Skov, L. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.09.036 · Cited by 164
The Role and Diagnosis of Allergic Contact Dermatitis in Patients with Atopic Dermatitis
Owen, J. L., Vakharia, P. P., & Silverberg, J. I. (2018) · American Journal of Clinical Dermatology · doi:10.1007/s40257-017-0340-7 · Cited by 163
Glial influences on BBB functions and molecular players in immune cell trafficking
Lécuyer, M.-A., Kebir, H., & Prat, A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.004 · Cited by 163
Self-citationInterleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse
Wang, H. H., Dai, Y. Q., Qiu, W., Lu, Z. Q., Peng, F. H., Wang, Y. G., Bao, J., Li, Y., & Hu, X. Q. (2011) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2011.01.031 · Cited by 164
Romagnani, S. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2392 · Cited by 163
Multiple sclerosis and the role of immune cells
Høglund, R. A. (2014) · World Journal of Experimental Medicine · doi:10.5493/wjem.v4.i3.27 · Cited by 161
Chen, K., & Kolls, J. K. (2017) · Gene · doi:10.1016/j.gene.2017.01.016 · Cited by 164
“Human TH17 cells have been shown to efficiently transmigrate across the blood-brain barrier in multiple sclerosis lesions, promoting central nervous system inflammation (Kebir et al., 2007).”
BackgroundCurcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases
Sadeghi, M., Dehnavi, S., Asadirad, A., Xu, S., Majeed, M. A., Jamialahmadi, T., Johnston, T. P., & Sahebkar, A. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01136-w · Cited by 190
Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells
Garretti, F., Agalliu, D., Lindestam Arlehamn, C. S., Sette, A., & Sulzer, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00303 · Cited by 162
“Th17 cells seem to exert their neurotoxic effects by releasing IL-17A, which interferes with the remyelination process (98) and directly damages the BBB (99).”
BackgroundLiu, L., Li, Y., Peng, H., Liu, R., Ji, W., Shi, Z., Shen, J., Ma, G., & Zhang, X. (2020) · Science Advances · doi:10.1126/sciadv.aba3967 · Cited by 160
A Proinflammatory Role for Interleukin-22 in the Immune Response to Hepatitis B Virus
Zhang, Y., Cobleigh, M. A., Lian, J., Huang, C., Booth, C. J., Bai, X., & Robek, M. D. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.051 · Cited by 162
Pfeiffer, F., Schäfer, J., Lyck, R., Makrides, V., Brunner, S., Schaeren-Wiemers, N., Deutsch, U., & Engelhardt, B. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0883-2 · Cited by 160
Ni, P., Dong, H., Wang, Y., Zhou, Q., Xu, M., Qian, Y., & Sun, J. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1374-3 · Cited by 161
“Hania Kebir demonstrated that human CNS postmortem materials from heavily inflamed MS individuals showed more IL-17R expression on the endothelium compared with unaffected control individuals [54].”
Metadata
- Authors
- Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A.
- Affiliations
- University of Zurich (CH)
- Hôpital Notre-Dame (CA)
- University of Alberta (CA)
- Corresponding author
- Prat, Alexandre
- Venue
- Nature Medicine
- Published
- 2007-09-09
- Volume
- 13
- Issue
- 10
- Pages
- 1173-1175
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC5114125
- OpenAlex
- W1998000193
- Semantic Scholar
- d0c491686d390e0dfdffedd4e32222d5b6065fd7
- Cited by
- 1,759
- References
- 14
- Citations by year
- 2026: 69 · 2025: 78 · 2024: 85 · 2023: 116 · 2022: 104 · 2021: 86 · 2020: 96 · 2019: 87 · 2018: 98 · 2017: 98 · 2016: 90 · 2015: 94 · 2014: 97 · 2013: 106 · 2012: 86
- FWCI
- 54.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Funders
- Canadian Institutes of Health Research (79785_1)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- Th17 cells, blood-brain barrier, endothelial cells, IL-17, IL-22, tight junctions, multiple sclerosis, neuroinflammation, lymphocyte transmigration, granzyme B
- MeSH terms
- Blood-Brain Barrier, Cell Membrane Permeability, Cell Movement, Cells, Cultured, Central Nervous System, Dose-Response Relationship, Drug, Endothelium, Vascular, T-Lymphocytes, Helper-Inducer, Humans, Inflammation, Multiple Sclerosis, CD4-Positive T-Lymphocytes, Case-Control Studies, Receptors, Interleukin, Tight Junctions, Interleukin-17, Endothelial Cells, Granzymes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.